Suchergebnisse

Nektar Therapeutics (NKTR) closed the last trading session at $73.25, gaining 2.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Omada Health, Inc. (OMDA) closed the last trading session at $14.53, gaining 28.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Shares of Ultra Clean Holdings (UCTT) have gained 0.6% over the past four weeks to close the last trading session at $55.72, but there could still be a solid upside left in the stock if short-term

Alarm.com Holdings (ALRM) closed the last trading session at $46.15, gaining 1.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Shares of HCI Group (HCI) have gained 0.7% over the past four weeks to close the last trading session at $161.18, but there could still be a solid upside left in the stock if short-term price

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

FactSet Research (FDS) closed the last trading session at $208.84, gaining 5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Shares of Accelerant Holdings (ARX) have gained 26.2% over the past four weeks to close the last trading session at $12.95, but there could still be a solid upside left in the stock if short-term

Prothena (PRTA) closed the last trading session at $9.31, gaining 4.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Cable One (CABO) closed the last trading session at $96.24, gaining 5.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

PubMatic, Inc. (PUBM) closed the last trading session at $8.31, gaining 17.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Ooma (OOMA) closed the last trading session at $14.55, gaining 13.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

Life and

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

We know